Skip to contentSkip to Braille Studio

Library / Laws / 116th Congress / House Bills / H.R. 2855

H.R. 2855

To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.

Print stageDateSize⠃
Introduced in House2019-05-20767 B⠃⠗⠋